India is well positioned to attract future investments: Patrick Johnson, President, Lilly International

Read post on economictimes.indiatimes.com

Faster ApprovalsFaster, predictable, and globally aligned clinical trial approvals are critical for India to attract high-value research and strengthen scientific capability and capacityPatrick JohnsonExecutive Vice President of Eli Lilly and Company and President of Lilly International